4.2 Review

Fragile X Syndrome: The GABAergic System and Circuit Dysfunction

Journal

DEVELOPMENTAL NEUROSCIENCE
Volume 33, Issue 5, Pages 349-364

Publisher

KARGER
DOI: 10.1159/000329420

Keywords

Inhibition; Fragile X mental retardation protein; Synapse; Developmental disorder; Autism spectrum disorders; Cerebral cortex; Amygdala

Funding

  1. NIH/NINDS [R01NS053719]
  2. Autism Speaks
  3. FRAXA
  4. CIHR
  5. Epilepsy Foundation
  6. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053719] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Fragile X syndrome (FXS) is a neurodevelopmental disorder characterized by intellectual disability, sensory hypersensitivity, and high incidences of autism spectrum disorders and epilepsy. These phenotypes are suggestive of defects in neural circuit development and imbalances in excitatory glutamatergic and inhibitory GABAergic neurotransmission. While alterations in excitatory synapse function and plasticity are well-established in Fmr1 knockout (KO) mouse models of FXS, a number of recent electrophysiological and molecular studies now identify prominent defects in inhibitory GABAergic transmission in behaviorally relevant forebrain regions such as the amygdala, cortex, and hippocampus. In this review, we summarize evidence for GABAergic system dysfunction in FXS patients and Fmr1 KO mouse models alike. We then discuss some of the known developmental roles of GABAergic signaling, as well as the development and refinement of GABAergic synapses as a framework for understanding potential causes of mature circuit dysfunction. Finally, we highlight the GABAergic system as a relevant target for the treatment of FXS. Copyright (C) 2011 S. Karger AG, Basel

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available